Chronic mesenteric ischemia: When and how to intervene on patients with celiac/SMA stenosis

Juliëtte Blauw, Tomas Bulut, Paul Eenhoorn, Roland J. Beuk, Marjolein Brusse-Keizer, Jeroen Kolkman, Robert H. Geelkerken

    Research output: Contribution to journalArticleAcademicpeer-review

    4 Citations (Scopus)

    Abstract

    BACKGROUND: Studies that compared open surgical mesenteric artery repair (OSMAR) with percutaneous mesenteric artery stenting (PMAS) in patients with chronic mesenteric ischemia (CMI) are based on merely older studies in which only a minority of patients received PMAS. This does not reflect the current PMAS-first choice treatment paradigm. This article focused on the present opinions and changes in outcomes of OSMAR for CMI in the era of preferred use of PMAS.

    METHODS: Patients who received OSMAR for CMI from 1997 until 2014 in a tertiary referral centre for chronic mesenteric ischemia were included in this report. Patients were divided into two groups, the historical OSMAR preferred group and present PMAS preferred group.

    RESULTS: Patient characteristics, SVS comorbidity severity score, clinical presentation and number of diseased mesenteric arteries were not significantly changed after the widespread introduction of PMAS. In the present PMAS first era there were trends of less open surgical mesenteric artery multivessel repair, less antegrade situated bypasses, decreased clinical success but improved survival after OSMAR.

    CONCLUSIONS: Elective OSMAR should only be used in patients with substantial physiologic reserve and who have unfavourable mesenteric lesions, failed PMAS or multiple recurrences of in-stent stenosis/occlusion. PMAS in CMI patients is evolved from "bridge to surgery" to nowadays first choice treatment and "bridge to repeated PMAS" in almost all patients with CMI.

    Original languageEnglish
    Pages (from-to)321-328
    Number of pages8
    JournalJournal of Cardiovascular Surgery
    Volume58
    Issue number2
    DOIs
    Publication statusPublished - 1 Apr 2017

    Fingerprint

    Mesenteric Arteries
    Abdomen
    Pathologic Constriction
    Mesenteric Ischemia

    Keywords

    • Mesenteric ischemia
    • Vascular diseases
    • Vascular patency
    • Vascular surgical procedures

    Cite this

    Blauw, Juliëtte ; Bulut, Tomas ; Eenhoorn, Paul ; Beuk, Roland J. ; Brusse-Keizer, Marjolein ; Kolkman, Jeroen ; Geelkerken, Robert H. / Chronic mesenteric ischemia : When and how to intervene on patients with celiac/SMA stenosis. In: Journal of Cardiovascular Surgery. 2017 ; Vol. 58, No. 2. pp. 321-328.
    @article{2e8f7868b62d4103be49ddc28ee24ea9,
    title = "Chronic mesenteric ischemia: When and how to intervene on patients with celiac/SMA stenosis",
    abstract = "BACKGROUND: Studies that compared open surgical mesenteric artery repair (OSMAR) with percutaneous mesenteric artery stenting (PMAS) in patients with chronic mesenteric ischemia (CMI) are based on merely older studies in which only a minority of patients received PMAS. This does not reflect the current PMAS-first choice treatment paradigm. This article focused on the present opinions and changes in outcomes of OSMAR for CMI in the era of preferred use of PMAS.METHODS: Patients who received OSMAR for CMI from 1997 until 2014 in a tertiary referral centre for chronic mesenteric ischemia were included in this report. Patients were divided into two groups, the historical OSMAR preferred group and present PMAS preferred group. RESULTS: Patient characteristics, SVS comorbidity severity score, clinical presentation and number of diseased mesenteric arteries were not significantly changed after the widespread introduction of PMAS. In the present PMAS first era there were trends of less open surgical mesenteric artery multivessel repair, less antegrade situated bypasses, decreased clinical success but improved survival after OSMAR. CONCLUSIONS: Elective OSMAR should only be used in patients with substantial physiologic reserve and who have unfavourable mesenteric lesions, failed PMAS or multiple recurrences of in-stent stenosis/occlusion. PMAS in CMI patients is evolved from {"}bridge to surgery{"} to nowadays first choice treatment and {"}bridge to repeated PMAS{"} in almost all patients with CMI.",
    keywords = "Mesenteric ischemia, Vascular diseases, Vascular patency, Vascular surgical procedures",
    author = "Juli{\"e}tte Blauw and Tomas Bulut and Paul Eenhoorn and Beuk, {Roland J.} and Marjolein Brusse-Keizer and Jeroen Kolkman and Geelkerken, {Robert H.}",
    year = "2017",
    month = "4",
    day = "1",
    doi = "10.23736/S0021-9509.16.09829-3",
    language = "English",
    volume = "58",
    pages = "321--328",
    journal = "Journal of Cardiovascular Surgery",
    issn = "0021-9509",
    publisher = "Edizioni Minerva Medica S.p.A.",
    number = "2",

    }

    Chronic mesenteric ischemia : When and how to intervene on patients with celiac/SMA stenosis. / Blauw, Juliëtte; Bulut, Tomas; Eenhoorn, Paul; Beuk, Roland J.; Brusse-Keizer, Marjolein; Kolkman, Jeroen; Geelkerken, Robert H.

    In: Journal of Cardiovascular Surgery, Vol. 58, No. 2, 01.04.2017, p. 321-328.

    Research output: Contribution to journalArticleAcademicpeer-review

    TY - JOUR

    T1 - Chronic mesenteric ischemia

    T2 - When and how to intervene on patients with celiac/SMA stenosis

    AU - Blauw, Juliëtte

    AU - Bulut, Tomas

    AU - Eenhoorn, Paul

    AU - Beuk, Roland J.

    AU - Brusse-Keizer, Marjolein

    AU - Kolkman, Jeroen

    AU - Geelkerken, Robert H.

    PY - 2017/4/1

    Y1 - 2017/4/1

    N2 - BACKGROUND: Studies that compared open surgical mesenteric artery repair (OSMAR) with percutaneous mesenteric artery stenting (PMAS) in patients with chronic mesenteric ischemia (CMI) are based on merely older studies in which only a minority of patients received PMAS. This does not reflect the current PMAS-first choice treatment paradigm. This article focused on the present opinions and changes in outcomes of OSMAR for CMI in the era of preferred use of PMAS.METHODS: Patients who received OSMAR for CMI from 1997 until 2014 in a tertiary referral centre for chronic mesenteric ischemia were included in this report. Patients were divided into two groups, the historical OSMAR preferred group and present PMAS preferred group. RESULTS: Patient characteristics, SVS comorbidity severity score, clinical presentation and number of diseased mesenteric arteries were not significantly changed after the widespread introduction of PMAS. In the present PMAS first era there were trends of less open surgical mesenteric artery multivessel repair, less antegrade situated bypasses, decreased clinical success but improved survival after OSMAR. CONCLUSIONS: Elective OSMAR should only be used in patients with substantial physiologic reserve and who have unfavourable mesenteric lesions, failed PMAS or multiple recurrences of in-stent stenosis/occlusion. PMAS in CMI patients is evolved from "bridge to surgery" to nowadays first choice treatment and "bridge to repeated PMAS" in almost all patients with CMI.

    AB - BACKGROUND: Studies that compared open surgical mesenteric artery repair (OSMAR) with percutaneous mesenteric artery stenting (PMAS) in patients with chronic mesenteric ischemia (CMI) are based on merely older studies in which only a minority of patients received PMAS. This does not reflect the current PMAS-first choice treatment paradigm. This article focused on the present opinions and changes in outcomes of OSMAR for CMI in the era of preferred use of PMAS.METHODS: Patients who received OSMAR for CMI from 1997 until 2014 in a tertiary referral centre for chronic mesenteric ischemia were included in this report. Patients were divided into two groups, the historical OSMAR preferred group and present PMAS preferred group. RESULTS: Patient characteristics, SVS comorbidity severity score, clinical presentation and number of diseased mesenteric arteries were not significantly changed after the widespread introduction of PMAS. In the present PMAS first era there were trends of less open surgical mesenteric artery multivessel repair, less antegrade situated bypasses, decreased clinical success but improved survival after OSMAR. CONCLUSIONS: Elective OSMAR should only be used in patients with substantial physiologic reserve and who have unfavourable mesenteric lesions, failed PMAS or multiple recurrences of in-stent stenosis/occlusion. PMAS in CMI patients is evolved from "bridge to surgery" to nowadays first choice treatment and "bridge to repeated PMAS" in almost all patients with CMI.

    KW - Mesenteric ischemia

    KW - Vascular diseases

    KW - Vascular patency

    KW - Vascular surgical procedures

    UR - http://www.scopus.com/inward/record.url?scp=85015596566&partnerID=8YFLogxK

    U2 - 10.23736/S0021-9509.16.09829-3

    DO - 10.23736/S0021-9509.16.09829-3

    M3 - Article

    VL - 58

    SP - 321

    EP - 328

    JO - Journal of Cardiovascular Surgery

    JF - Journal of Cardiovascular Surgery

    SN - 0021-9509

    IS - 2

    ER -